Profil bibliographique

Grace R. Tarabay

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées
0Citations signalées
2Affiliations récentes

Les institutions déclarées

Beaver Medical GroupUniversity of Pittsburgh Medical Center

Les domaines associés

Hepatocellular Carcinoma Treatment and PrognosisLung Cancer Treatments and MutationsBladder and Urothelial Cancer TreatmentsColorectal Cancer Treatments and StudiesCholangiocarcinoma and Gallbladder Cancer Studies

Les publications récentes

Accès ouvert 2023 conference-abstract OpenAlex

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48).

Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Chih‐Yi Liao et autres

e16330 Background: Immune checkpoint blockade has improved outcomes in multiple tumor types, however little is known about the efficacy of these agents in rare tumors. We report the results of the gallbladder cohort of SWOG S1609 Dual Anti–CTLA-4 and anti–PD-1 blockade in …

us, gb (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2015 conference-abstract OpenAlex

Phase I/II study of rilotumumab (R) and erlotinib (E) in previously treated patients (pts) with metastatic NSCLC.

Ahmad A. Tarhini, Imran Rafique, Phu N. Tran, William E. Gooding et autres

8092 Background: MET is frequently overexpressed in NSCLC. Amplification of MET and its ligand (HGF), are mechanisms of resistance to EGFR inhibitors. R is an IgG2 human mAb that targets HGF. This phase I/II trial evaluated the safety and recommended phase 2 …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.